Simvastatin-Ezetimibe Compared With Simvastatin Monotherapy Among Patients 75 Years or Older
JAMA Cardiology Author Interviews
00:00
Final Takeaways and Guideline Outlook
Gotto urges discussion of benefits for those over 75 and notes awaiting trials before major guideline shifts.
Play episode from 26:03
Transcript
